Literature DB >> 1860634

Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pigs.

T Takahashi1, S Kurosawa, J W Wiley, C Owyang.   

Abstract

To test the hypothesis that domperidone stimulates gastric muscle contraction by antagonizing the inhibitory effects of dopamine on postsynaptic cholinergic neurons in the myenteric plexus, the effects of dopamine on circular muscle from the body of the guinea pig stomach were examined. Dopamine inhibited circular muscle contraction evoked by electric field stimulation in a dose-related manner. The threshold dose was 10(-6) mol/L and half-maximal inhibition occurred at 10(-5) mol/L. Preincubation of muscle contraction with atropine or tetrodotoxin abolished the contractile response to electric field stimulation, indicating mediation via a cholinergic pathway. The adrenergic antagonists phentolamine and propranolol and the DA1 antagonist SCH 23390 were ineffective in antagonizing the action of dopamine. In contrast, the DA2 antagonist domperidone blocked the inhibitory effect of dopamine on electric field stimulation-mediated contractions. Schild analysis showed a Ki of 3 x 10(-8) mol/L and a slope of unity. In addition, it was shown that dopamine inhibited veratridine-evoked release of [3H]acetylcholine from the gastric myenteric plexus in a dose-related manner (median effective dose, 5.2 x 10(-5) mol/L). Tetrodotoxin abolished [3H]acetylcholine release evoked by veratridine, but hexamethonium had no effect. Domperidone, but not SCH 23390, antagonized the inhibitory action of dopamine. Pretreatment with pertussis toxin blocked the action of dopamine to inhibit evoked release of [3H]acetylcholine. These observations indicate that dopamine inhibits gastric muscle contraction evoked by electric field stimulation by inhibiting cholinergic transmission. This is mediated by DA2 receptors located on the postganglionic cholinergic neurons, and the pathway involves a pertussis toxin-sensitive G protein. The DA2-receptor antagonist domperidone antagonizes the inhibitory effect of dopamine, resulting in stimulation of gastric muscle contraction. This provides a mechanism for the gastrokinetic effect of domperidone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860634     DOI: 10.1016/0016-5085(91)90528-s

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  Alteration of dopamine D2 receptors in human malignant stomach tissue.

Authors:  S Basu; P S Dasgupta
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats.

Authors:  L Wang; N P Murphy; A Stengel; M Goebel-Stengel; D H St Pierre; N T Maidment; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-03-23       Impact factor: 3.598

3.  Effects of several endothelin receptor antagonists on gastrointestinal transit of guinea pigs.

Authors:  K Kuwahara; Y Kitsukawa; Y Suzuki; Y Saito
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

4.  Buspirone, a new drug for the management of patients with ineffective esophageal motility?

Authors:  Charlotte Scheerens; Jan Tack; Nathalie Rommel
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

5.  Idiopathic and Diabetic Gastroparesis.

Authors:  Deirdre O'Donovan; Christine Feinle-Bisset; Karen Jones; Michael Horowitz
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

6.  The effect of dopamine on lung liquid production by in vitro lungs from fetal guinea-pigs.

Authors:  B A Chua; A M Perks
Journal:  J Physiol       Date:  1998-11-15       Impact factor: 5.182

7.  Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux.

Authors:  Bhavneesh Sharma; Manisha Sharma; Mradul Kumar Daga; Gopal Krishan Sachdev; Elliott Bondi
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

8.  The D2/D3 agonist PD128907 (R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) inhibits stimulated pyloric relaxation and spontaneous gastric emptying.

Authors:  Purna Kashyap; Maria-Adelaide Micci; Sarina Pasricha; Pankaj Jay Pasricha
Journal:  Dig Dis Sci       Date:  2008-07-04       Impact factor: 3.199

Review 9.  Diabetic gastroparesis. A critical reappraisal of new treatment strategies.

Authors:  J P Drenth; L G Engels
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 10.  Domperidone. A review of its use in diabetic gastropathy.

Authors:  A Prakash; A J Wagstaff
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.